Beta Drugs Ipo Price

Beta drugs ipo price

Business description from prospectus – Beta Drugs is primarily engaged in the manufacturing of oncology products.

Beta drugs ipo price

Its products range from anticancer tablets, capsules, injections and lyophilized injections. The company started production of oncology products by manufacturing portfolio of over 35 products which is used for the treatment of various cancer disease.

Beta drugs ipo price

As on March 31, 2017, the company had a portfolio of over 50 products products catering to various oncology diseases including breast, brain, bone, lung, mouth, head & neck, prostate, haematology, cervics, oeaophagus etc.

It has increased its product range, starting from 35 in 2015-16 to 50 active products in 2016-17. The company’s oncology portfolio includes key brands like Admine, Adgef, Addplatin, Erlotad etc.

Promoters of Beta Drugs – Vijay Kumar Batra

Beta Drugs IPO details

Subscription Dates29 Sep – 4 Oct 2017
IPO Price bandINR85 per share
Fresh issue 2,296,000 shares (INR19.52 crore)
Offer for sale Nil
Total IPO size2,296,000 shares (INR19.52 crore)
Minimum bid (lot size)1,600 shares
Face Value INR10 per share
Retail Allocation50%
Listing OnNSE Emerge SME platform
Beta Drugs’ financial performance (in INR lakh)
Total revenue313.0138.426.22,639.54,168.2
Total expenses308.6136.237.72,526.13,650.2
Profit after tax4.42.211.4113.4517.9

Beta Drugs Limited
Village Nandpur
Himachal Pradesh-17410

Phone: +91 01795 236196
Email:[email protected]


Subscription (no.

Beta drugs ipo price

of times)

Day 10.08
Day 20.66
Day 317.87


Earnings Per Share (EPS): INR8.69

Price/Earnings (P/E) ratio: 9.78

Return on Net Worth (RONW): 70.18%

Net Asset Value (NAV): INR12.39 per share

Link Intime India Private Limited
C-101, 247 Park, L.B.S.

Vikhroli (West), Mumbai – 400 083
Maharashtra, India

Phone: +91 22 4918 6200
Fax: +91 22 4918 6195
Email: [email protected]

Beta Drugs IPO allotment status is now available on Link Intime’s website.


Click on this link to get allotment status.

IPO Opening Date: 29 September 2017

IPO Closing Date: 4 October 2017

Finalisation of Basis of Allotment: 9 October 2017

Initiation of refunds: 10 October 2017

Transfer of shares to demat accounts: 11 October 2017

Listing Date: 12 October 2017

Listing Price on NSE SME: INR102 per share (up 20% from IPO price)

Closing Price on NSE SME: INR101.95 per share (up 19.94% from IPO price)